Ramesh Jayapal, Limdi Jimmy K, Sharma Vikram, Makin Alistair J
Department of Gastroenterology, Manchester Royal Infirmary, Manchester, UK.
Gastrointest Endosc. 2008 Nov;68(5):877-82. doi: 10.1016/j.gie.2008.02.065. Epub 2008 Jun 4.
There is a relative dearth of literature on the definitive endoscopic management of bleeding gastric varices. Variceal ligation with bands and detachable snares, sclerosants, cyanoacrylate glue, and thrombin injections have been used with variable success.
To report our experience with bovine thrombin injection for the treatment of bleeding gastric varices.
A retrospective review.
Tertiary-referral hospital.
Forty-two cases of gastric varices were identified from our endoscopy database between July 1998 and July 2003. Thirteen patients had thrombin injection.
Thrombin injection therapy for bleeding gastric varices.
Control of hemorrhage, risk of rebleeding, and mortality.
Of the 13 patients who underwent thrombin injections, hemostasis in the acute setting was successful in 92% of cases. Patients received 1 to 4 sessions of thrombin, with a mean total dose of 10.8 mL for variceal eradication. One patient continued to bleed and needed a transjugular intrahepatic portosystemic shunt as a rescue procedure. The patient with hepatocellular carcinoma died within 30 days, and 4 more patients died after a median follow-up of 22 months; none died because of bleeding. There was no rebleeding in the remaining patients at a median follow-up of 25 months.
The retrospective nature and small number.
In our series, injection with thrombin proved to be an effective endoscopic treatment in the majority of patients with bleeding gastric varices. The overall mortality, after controlling bleeding, was 38% (5/13), subsequent to a median follow-up of 22 months.
关于胃静脉曲张出血的确定性内镜治疗的文献相对较少。使用带结扎和可脱性圈套器进行静脉曲张结扎、硬化剂、氰基丙烯酸酯胶和凝血酶注射,其成功率各不相同。
报告我们使用牛凝血酶注射治疗胃静脉曲张出血的经验。
回顾性研究。
三级转诊医院。
从1998年7月至2003年7月我们的内镜数据库中识别出42例胃静脉曲张患者。13例患者接受了凝血酶注射。
凝血酶注射治疗胃静脉曲张出血。
出血控制、再出血风险和死亡率。
在接受凝血酶注射的13例患者中,92%的患者在急性出血期止血成功。患者接受了1至4次凝血酶注射,平均总剂量为10.8 mL以根除静脉曲张。1例患者持续出血,需要行经颈静脉肝内门体分流术作为挽救措施。1例肝细胞癌患者在30天内死亡,另有4例患者在中位随访22个月后死亡;均非因出血死亡。其余患者在中位随访25个月时未再出血。
研究的回顾性性质及样本量小。
在我们的系列研究中,凝血酶注射被证明是大多数胃静脉曲张出血患者有效的内镜治疗方法。在中位随访22个月后,控制出血后的总体死亡率为38%(5/13)。